Table 1.
HR, min−1 | LVSP, mmHg | LVDP, mmHg | +dP/dt, mmHg/sec | −dP/dt, mmHg/sec | τ, msec | n | |
---|---|---|---|---|---|---|---|
Uninfected | 302 ± 21 | 92.5 ± 3.5 | 5.2 ± 1.1 | 5,225 ± 136 | −3,805 ± 97 | 18.5 ± 1.0 | 6 |
Ad.βgal day 2 | 286 ± 19 | 92.6 ± 5.9 | 6.3 ± 1.6 | 5,108 ± 167 | −3,765 ± 121 | 20.8 ± 2.1 | 6 |
Ad.PL day 2 | 270 ± 26 | 58.3 ± 12.9* | 12.7 ± 2.9* | 3,210 ± 298* | −2,117 ± 178* | 33.4 ± 3.2* | 8 |
Ad.βgal day 7 | 290 ± 22 | 88.5 ± 5.0 | 6.5 ± 1.3 | 5,032 ± 234 | −3,668 ± 112 | 21.1 ± 2.4 | 6 |
Ad.PL day 7 | 342 ± 31 | 54.2 ± 8.2† | 9.8 ± 2.3 | 3,345 ± 311† | −2,345 ± 154† | 32.4 ± 1.9† | 8 |
All data presented as mean ± SD. LVSP, left ventricular systolic pressure; LVDP, left ventricular end-diastolic pressure; HR, heart rate; +dP/dt, maximal rate of pressure rise; −dP/dt, maximal rate of pressure fall; τ, time constant of relaxation; n, number of hearts.
P < 0.01 compared to uninfected and Ad.βgal, day 2.
P < 0.01 compared to Ad.βgal, day 7.